Themes US Cash Flow Champions ETF (NASDAQ: USCF)

Latest news for Themes US Cash Flow Champions ETF (NASDAQ:USCF)

Financial Services

Energy

Healthcare

Technology

Consumer Defensive

Consumer Cyclical

Basic Materials

Communication Services

Industrials

To pursue its objective, the fund employs a passive management (or indexing) investment approach designed to track the performance, before fees and expenses, of the Solactive US Cash Flow Champions Index, or any successor thereto (the Index). The Index is based on a proprietary methodology developed and maintained by Solactive AG (the Index Provider), which is an organization that is independent of, and unaffiliated with, the Fund and Themes Management Company, LLC, the Funds investment adviser (the Adviser).

Broadcom Inc

Exxon Mobil Corp.

Jpmorgan Chase & Co.

Chevron Corp.

Abbvie Inc.

Pfizer, Inc.

American Express Co.

Conocophillips Co

Progressive Corp.

Regeneron Pharmaceuticals, Inc.

Themes US Cash Flow Champions ETF

USCF ETF Trust USCF Aluminum Strategy Fund

USCF ETF Trust USCF Dividend Income Fund

USCF ETF Trust USCF Energy Commodity Strategy Absolute Return Fund

USCF ETF Trust USCF Sustainable Battery Metals Strategy Fund

USCF ETF Trust USCF Sustainable Commodity Strategy Fund

USCF Gold Strategy Plus Income Fund

USCF Midstream Energy Income Fund ETF

USCF SummerHaven Dynamic Commodity Strategy No K-1 Fund

Xylem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYL#NYSE">XYL</a>) has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $157.18, a high estimate of $172.00, and a low estimate of $135.00. Witnessing a positive shift, the current average has risen by 6.07% from the previous average price target of $148.18.
<img src="https://www.benzinga.com/files/images/story/2024/1722452456_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
A comprehensive examination of how financial experts perceive Xylem is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Halloran</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$170.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$172.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Deane Dray</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$163.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$170.00</td>
<td>$157.00</td>
</tr>
<tr>
<td>Joseph Giordano</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$138.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Bryan Blair</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$152.00</td>
<td>$147.00</td>
</tr>
<tr>
<td>John Eade</td>
<td>Argus Research</td>
<td>Raises</td>
<td>Buy</td>
<td>$165.00</td>
<td>$146.00</td>
</tr>
<tr>
<td>Deane Dray</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$162.00</td>
<td>$157.00</td>
</tr>
<tr>
<td>Bryan Blair</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$147.00</td>
<td>$142.00</td>
</tr>
<tr>
<td>Brett Linzey</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$135.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Michael Halloran</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$155.00</td>
<td>$151.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Xylem. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Xylem compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Xylem's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Xylem's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/XYL/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Xylem analyst ratings.</a>
<h2>About Xylem</h2>
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $7.4 billion in revenue in 2023.
<h3>Financial Insights: Xylem</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Over the 3 months period, Xylem showcased positive performance, achieving a revenue growth rate of 40.4% as of 31 March, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Industrials sector.
Net Margin: Xylem's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 7.53%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Xylem's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 1.5%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Xylem's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.96%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Xylem's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.23.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Beyond The Numbers: 11 Analysts Discuss Xylem Stock

TD Cowen analyst Doug Creutz maintains Electronic Arts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EA#NASDAQ">EA</a>) with a Buy and raises the price target from $163 to $183.

News

Price Target

TD Cowen Maintains Buy on Electronic Arts, Raises Price Target to $183

Providing a diverse range of perspectives from bullish to bearish, 13 analysts have published ratings on 3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) in the last three months.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $127.62, a high estimate of $150.00, and a low estimate of $95.00. Surpassing the previous average price target of $105.56, the current average has increased by 20.9%.
<img src="https://www.benzinga.com/files/images/story/2024/1722452445_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of 3M among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nicole Deblase</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$150.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>John Eade</td>
<td>Argus Research</td>
<td>Announces</td>
<td>Buy</td>
<td>$145.00</td>
<td>-</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$133.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$145.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Andrew Obin</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$143.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Deane Dray</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Underperform</td>
<td>$95.00</td>
<td>$93.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$120.00</td>
<td>$118.00</td>
</tr>
<tr>
<td>Joe O'Dea</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$110.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Nigel Coe</td>
<td>Wolfe Research</td>
<td>Announces</td>
<td>Outperform</td>
<td>$125.00</td>
<td>-</td>
</tr>
<tr>
<td>Andrew Obin</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$120.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$118.00</td>
<td>$112.00</td>
</tr>
<tr>
<td>Jeffrey Sprague</td>
<td>Vertical Research</td>
<td>Raises</td>
<td>Buy</td>
<td>$140.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Wesley Brooks</td>
<td>HSBC</td>
<td>Raises</td>
<td>Buy</td>
<td>$115.00</td>
<td>$91.13</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to 3M. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of 3M compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for 3M's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
To gain a panoramic view of 3M's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/MMM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on 3M analyst ratings.</a>
<h2>Delving into 3M's Background</h2>
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.
<h3>Key Indicators: 3M's Financial Health</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Challenges: 3M's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -0.45%. This indicates a decrease in top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: 3M's net margin excels beyond industry benchmarks, reaching 18.31%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 26.08%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): 3M's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.32% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: 3M's debt-to-equity ratio surpasses industry norms, standing at 3.5. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Analyst Ratings: Simplified</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Closer Look at 13 Analyst Recommendations For 3M

Throughout the last three months, 7 analysts have evaluated CommVault Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVLT#NASDAQ">CVLT</a>), offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated CommVault Systems and provided 12-month price targets. The average target is $140.29, accompanied by a high estimate of $170.00 and a low estimate of $122.00. This upward trend is apparent, with the current average reflecting a 13.93% increase from the previous average price target of $123.14.
<img src="https://www.benzinga.com/files/images/story/2024/1722452431_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A clear picture of CommVault Systems's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Thomas Blakey</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$170.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Dan Bergstrom</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$152.00</td>
<td>$121.00</td>
</tr>
<tr>
<td>James Fish</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$123.00</td>
<td>$107.00</td>
</tr>
<tr>
<td>Thomas Blakey</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$140.00</td>
<td>$122.00</td>
</tr>
<tr>
<td>Howard Ma</td>
<td>Guggenheim</td>
<td>Maintains</td>
<td>Buy</td>
<td>$122.00</td>
<td>$122.00</td>
</tr>
<tr>
<td>Rudy Kessinger</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Buy</td>
<td>$135.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Aaron Rakers</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$140.00</td>
<td>$125.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to CommVault Systems. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of CommVault Systems compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of CommVault Systems's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into CommVault Systems's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CVLT/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on CommVault Systems analyst ratings.</a>
<h2>About CommVault Systems</h2>
CommVault Systems Inc provides data and information management software applications and services. The firm sells software licenses and services to large global enterprises, small- and midsize businesses, and government agencies through both its salesforce and its network of reseller partners. Its software solutions include Commvault Complete Backup and Recovery, HyperScale, Hedvig, and Metallic. The company operates in the United States and exports to many other countries.
<h3>CommVault Systems's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: CommVault Systems displayed positive results in 3 months. As of 31 March, 2024, the company achieved a solid revenue growth rate of approximately 9.74%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: CommVault Systems's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 56.48%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): CommVault Systems's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 55.72% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): CommVault Systems's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 14.43% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: CommVault Systems's debt-to-equity ratio is below the industry average. With a ratio of 0.04, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CVLT

A Closer Look at 7 Analyst Recommendations For CommVault Systems

Pinnacle West Capital's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNW#NYSE">PNW</a>) short percent of float has fallen 10.54% since its last report. The company recently reported that it has 4.63 million shares sold short, which is 4.67% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.89 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Pinnacle West Capital Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1722452423_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Pinnacle West Capital has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Pinnacle West Capital's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Pinnacle West Capital's peer group average for short interest as a percentage of float is 2.23%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

How Is The Market Feeling About Pinnacle West Capital?

Cisco Systems's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NYSE">CSCO</a>) short percent of float has risen 16.81% since its last report. The company recently reported that it has 56.15 million shares sold short, which is 1.39% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.29 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Cisco Systems Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1722452418_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Cisco Systems has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Cisco Systems's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Cisco Systems's peer group average for short interest as a percentage of float is 8.46%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

CSCO

Looking Into Cisco Systems's Recent Short Interest

Medpace Hldgs's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NYSE">MEDP</a>) short percent of float has fallen 15.66% since its last report. The company recently reported that it has 833 thousand shares sold short, which is 4.04% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.7 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Medpace Hldgs Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1722452413_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Medpace Hldgs has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Medpace Hldgs's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Medpace Hldgs's peer group average for short interest as a percentage of float is 5.61%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

MEDP

Looking Into Medpace Hldgs's Recent Short Interest

Millions of Americans count on their 401(k)s to fund their golden years, but many are missing out on big bucks due to common misunderstandings. A <a href="https://www.gao.gov/products/gao-21-357">U.S. Government Accountability Office</a> report found that 41% of people don&#8217;t even realize they&#8217;re paying fees on their 401(k).&nbsp;
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/red-ventures"> The percentage may shock you</a>.</li>
</ul>
It&#8217;s no wonder people are confused. Between juggling work and family, staying on top of financial details is tough. Stuart Robertson, CEO of ShareBuilder 401(k), explains it best in a Forbes article: &#8220;Employees are busy managing their day-to-day lives and don&#8217;t regularly review their 401(k) to be aware of costs.&#8221;&nbsp;
Contribution confusion: <a href="https://www.benzinga.com/personal-finance/24/07/39916548/6-in-10-employees-think-theyre-contributing-to-a-401-k-but-arent-saving-at-all-are-you-one-of-th">59% of non-contributing employees</a> mistakenly believe they're contributing to their 401(k), according to a Principal Financial Group survey. In reality, they aren't saving at all. This error can lead to years of missed savings opportunities, a significant shortfall in retirement funds, and a huge disappointment.
See Also: <a href="https://www.benzinga.com/money/irs-finalizes-10-year-rule-adv">IRS Finalizes 10-Year Rule For Retirement Withdrawals, Making Things &#8216;Even More Insanely Complicated&#8217;</a>
Automatic enrollment assumptions: Many employees assume they&#8217;re automatically enrolled in their company&#8217;s 401(k) when they start a job. However, this isn&#8217;t always the case. The SECURE Act 2.0, set to take effect in 2025, will require most new 401(k) plans to automatically enroll employees.
Contribution limits: For 2024, the <a href="https://www.irs.gov/newsroom/401k-limit-increases-to-23000-for-2024-ira-limit-rises-to-7000">IRS</a> has set the employee contribution limit for 401(k) plans at $23,000, with an additional $7,500 for those 50 and older. Since these limits can change annually, not everyone keeps up with the latest rules and limits. Knowing the limits helps maximize your contributions to grow your nest egg.&nbsp;
Employer matching impact: Employer matching can significantly boost retirement savings. According to Forbes, many employees don&#8217;t fully understand or take advantage of this benefit, leaving free money on the table. Studies suggest that contributing at least 15% of your income each year to your 401(k) accounts can help ensure adequate retirement savings.
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: A billion-dollar investment strategy with minimums as low as $10 —<a href="https://www.benzinga.com/money/fundrise-flagship-fund"> you can become part of the next big real estate boom today.</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
Vesting schedules: Some employees confuse their contributions, which are always 100% vested, with employer contributions, which may vest over time. This misunderstanding can lead to surprises if an employee leaves a job before fully vested in the employer&#8217;s contributions.
Can&#8217;t Lose Money Myth: There's a dangerous misconception that you can&#8217;t lose money in a 401(k). While these plans offer tax advantages and potential employer matches, their investments can lose value, especially during market downturns. The U.S. Securities and Exchange Commission warns that 401(k) investments are not guaranteed and can decrease in value. Understanding this risk is key to making informed investment decisions within your 401(k).
See Also: These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a>
Inflation adjustment: Many retirement calculations ignore <a href="https://www.benzinga.com/general/education/24/05/38905994/suze-orman-says-ditch-the-4-retirement-rule-five-strategies-suggested-by-the-finance-guru-for-s">inflation&#8217;s impact on future purchasing power</a>. Based on Bureau of Labor Statistics reports, inflation averages about 3% annually over the long term. Failing to account for this can lead to a significant underestimation of retirement needs.
Tax implications: Some assume their retirement tax bracket will be lower, which isn&#8217;t always true. Depending on your income sources and changes in tax laws, you might find yourself in a similar or even higher tax bracket in retirement.
While 401(k)s are a wonderful way to build your nest egg, they can also be a little tricky to fully understand. <a href="https://www.benzinga.com/money/are-you-rich-advisor">Consider talking to a financial advisor</a> to make the most of your hard-earned cash. They can help clear things up in the confusing world of investments so you can relax knowing your retirement is on track.
Read Next:
<ul>
<li>Can you guess how many retire with a $5,000,000 nest egg? &#8211;<a href="https://www.benzinga.com/money/retire-5mil-nest-egg"> How does it compare to the average?</a></li>
<li>This billion-dollar fund has invested in the next big real estate boom,<a href="https://www.benzinga.com/money/fundrise-flagship-fund"> here's how you can join for $10.</a></li>
</ul>

Personal Finance

41% Of People Don't Realize They're Paying Fees On Their 401(k) – Here's Some Other Common Misconceptions

Over the past 24 hours, Internet Computer's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">ICP</a>) price has risen 6.6% to $9.48. This is contrary to its negative trend over the past week where it has experienced a 4.0% loss, moving from $9.76 to its current price. As it stands right now, the coin's all-time high is $700.65. 
The chart below compares the price movement and volatility for Internet Computer over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1722452405_0.png" alt="price_chart" />
The trading volume for the coin has fallen 8.0% over the past week, moving in tandem, directionally, with the overall circulating supply of the coin, which has decreased 0.24%. This brings the circulating supply to 467.19 million. According to our data, the current market cap ranking for ICP is #28 at $4.43 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1722452405_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

Movers

$ICP

Cryptocurrency Internet Computer's Price Increased More Than 6% Within 24 hours

Barclays analyst Tim Long maintains Corning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>) with a Equal-Weight and raises the price target from $36 to $40.

Barclays Maintains Equal-Weight on Corning, Raises Price Target to $40

WIIM

NRIX

Nurix Therapeutics shares are trading higher after Truist Securities initiated coverage on the stock with a Buy rating and announced a price target of $36.

VCNX

Vaccinex shares are trading lower. The company announced results of its early stage SIGNAL-AD clinical trial of pepinemab antibody in AD.

ALMS

Alumis shares are trading higher. The company announced it initiated Onward Phase 3 clinical program for ESK-001.

Graphjet Technology shares are trading higher after the company regained compliance status with the NASDAQ.

Barclays analyst Benjamin Theurer maintains Coca-Cola Femsa SAB de (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KOF#NYSE">KOF</a>) with a Overweight and raises the price target from $105 to $110.

Barclays Maintains Overweight on Coca-Cola Femsa SAB de, Raises Price Target to $110

Barclays analyst Tim Long maintains Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) with a Overweight and raises the price target from $320 to $341.

ANET

Barclays Maintains Overweight on Arista Networks, Raises Price Target to $341

On Tuesday,&nbsp;Pfizer Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) reported second-quarter adjusted EPS of $0.60, down 11% year over year, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $0.46</a>.
The U.S. drugmaker reported sales of $13.28 billion, up 2% year-over-year (up 3% operationally), beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/07/40037079/pfizer-marks-first-revenue-growth-since-covid-revenue-peak-in-2022-lifts-annual-guidance" rel="noreferrer noopener">consensus of $13.02 billion</a>.
Truist Securities sees the strong demand growth as highly encouraging and, at current levels, Pfizer shares are very attractive given the company&#8217;s diverse portfolio that is gaining momentum, effective cost-cutting initiatives, and a commitment to maintaining or growing an attractive dividend.
The analyst maintains the Buy rating, with a price target of $36.
Goldman Sachs notes that Pfizer&#8217;s performance included noteworthy standouts (Vyndaqel, Nurtec) and evidence that integration of the Seagen acquisition is progressing well.
Goldman Sachs analyst writes, &#8220;We were struck by the raised COVID-19 guidance, as we interpret the decision as being underpinned by confidence. Gross margin gains provide reassurance relative to concerns earlier in the year, as gains from cost realignment initiatives are materializing.&#8221;
The analyst keeps the Buy rating and raises the price target from $31 to $34.
BMO Capital Markets writes Pfizer&#8217;s (Outperform, $36 target) second-quarter earnings highlight the direction of the business as it moves out of the shadow of COVID.
With COVID revenue stabilizing, base revenue expanding, and clinical development focused on accelerating danuglipron in any way possible, BMO Capital analyst writes that the business&#8217;s priorities are aligned with shareholders.
Cantor Fitzgerald notes that concerns about Pfizer&#8217;s patent cliff and downside risk to COVID-19 sales will be offset by Seagen, new product launches, and M&amp;A expected to resume beyond 2025.
Also, along with the strong execution of its cost reduction programs, the updates could drive EPS to $3+ in 2025+ and the stock toward its price target of $45. Maintains <a target="_blank" href="https://www.benzinga.com/quote/PFE/analyst-ratings" rel="noreferrer noopener">the Overweight rating</a>.
Price Action: PFE stock is down 1.85% at $30.81 at last check Wednesday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/40075521/one-year-five-trial-failures-fibrogen-terminates-pancreatic-cancer-treatment-progra" target="_blank" rel="noreferrer noopener">One Year, Five Trial Failures: FibroGen Terminates Pancreatic Cancer Treatment Program</a>.</li>
</ul>

Analyst Color

Biotech

Equities

Large Cap

Health Care

Reiteration

General

Pfizer's Diverse Portfolio And Strong Execution Earn Analyst Praise Despite Patent Concerns

Court Denies Preliminary Approval of $335M Settlement in TKO Class-Action Lawsuits; Status Conference Set for August 19, 2024, and New Tentative Trial Date for October 28, 2024

<a href="https://www.youtube.com/watch?v=hb1eHcqGpY0" title="https://www.youtube.com/watch?v=hb1eHcqGpY0">https://www.youtube.com/watch?v=hb1eHcqGpY0</a>

Federal Reserve

Fed Chair Powell Says Upside Risks To Inflation Have Decreased; Downside Risks To Employment Mandate Are Real Now; Policy Rate Is Clearly Restrictive; Time Approaching to Start Rate Cuts; Time Coming When It Will Be Appropriate To Dial Back Restriction; 'Lot Of Data Between Now And September'

Rumors that Vice President Kamala Harris considered attending the Bitcoin 2024 conference have ignited discussions about a potential shift in the Democratic Party&#8217;s approach to cryptocurrency. Although the rumor was eventually debunked, sources close to the matter revealed that Harris's team gave the invitation "<a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39938175/vice-president-harris-snubs-bitcoin-conference-would-have-been-a-disaster-for-her-shrugs-o">serious consideration</a>."
<h3 class="wp-block-heading">A Possible Shift in Policy?</h3>
This news surprised many, given the current administration's generally hostile stance towards cryptocurrency. An anonymous crypto lobbyist and former White House advisor told Fortune, "<a href="https://fortune.com/crypto/2024/07/26/kamala-harris-likely-to-share-bitcoin-stance-in-coming-weeks-industry-optimists-note-her-husband-is-a-crypto-guy/">She doesn't have a lot of time to redefine herself</a>." The source suggested that Harris might use crypto policy to differentiate herself from President Joe Biden, potentially embracing tech and digital assets more openly.
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/events/digital-assets/"><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/30163546/905735A6-57D3-4874-9AA1-75D037842DB3-1-23.gif" alt="" class="wp-image-465992" style="width:384px;height:auto" /></a></figure>
Harris's background as a senator from California, where she developed strong relationships with tech industry leaders, adds another layer to the speculation. Gary DeWaal, a former senior trial attorney at the CFTC, noted, "[She] developed good relations with tech industry leaders."
<h3 class="wp-block-heading">Engagement with the Crypto Community</h3>
Further fueling the speculation, businessman Mark Cuban reportedly received multiple inquiries about crypto from Harris' camp. This outreach suggests a level of interest and engagement that contrasts sharply with the current administration's approach.
However, experts caution against jumping to conclusions. DeWaal believes Harris is unlikely to make any definitive statements on crypto before Aug. 7, when she's expected to announce her vice-presidential pick.
<h3 class="wp-block-heading">What's Next for Crypto Policy?</h3>
The evolving stance of political figures like Harris on cryptocurrency is a topic of great interest as the industry seeks clarity on future regulatory frameworks. The upcoming Benzinga Future of Digital Assets event on Nov. 19 in New York City will provide a platform for industry leaders and policymakers to discuss these developments and their implications for the future of digital assets in the United States. The event will gather digital asset companies and institutional investors for extensive networking opportunities, including 4,000 one-on-one meetings and executive roundtables.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/40077264/digital-asset-market-braces-for-political-shifts-as-trump-promises-changes-retribution-aga">Digital Asset Market Braces For Political Shifts As Trump Promises Changes, Retribution Against SEC Chair</a></li>
</ul>
Image via Shutterstock

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

Themes US Cash Flow Champions ETF

News

Latest news for Themes US Cash Flow Champions ETF (NASDAQ:USCF)